Table 1.
Patient clinical parameters and demographics.
| Clinical Information | Mean ± SD |
|---|---|
| Patient Age | 53 ± 10 |
| Tumor Grade (Elson) | |
| 1 | 8 |
| 2 | 60 |
| 3 | 12 |
| Ki67 (%) | 29 ± 16 |
| ER+ | 80 |
| PR+ | 74 |
| * HER2-neu+ | 0 |
| Triple Negative | 0 |
| ODX Score | |
| Low (≤17%) | 19 |
| Intermediate (18–30%) | 49 |
| High (≥31%) | 12 |
Estrogen Receptor (ER), Progesterone Receptor (PR), HER2-neu + (human growth factor receptor 2) * HER2-neu patients were excluded. ODX = OncotypeDX; Ki-67 is a histological marker for proliferation. Standard Deviation = SD; HER2 = human growth factor receptor 2; * HER2-neu patients were excluded.